The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design.

Kessler, Amy L; Bruno, Marco J; Buschow, Sonja I

Kessler, Amy L; Bruno, Marco J; Buschow, Sonja I.

Afiliação

Kessler AL; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Bruno MJ; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Buschow SI; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.

Vaccines (Basel) ; 8(4)2020 Dec 18.

Article em En | MEDLINE | ID: mdl-33353014

Palavras-chave

biomarker; cancer immunotherapy; immunopeptidomics; liquid biopsy; mass spectrometry; soluble human leukocyte antigens (sHLA)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Qualitative_research Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google